Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in Recurrent Malignant Gliomas
NCT00848523Phase 2Terminated
- Sponsor
- Neurological Surgery, P.C.
- Start
- Nov 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in malignant glioma, sponsored by Neurological Surgery, P.C.. Started Nov 2008; status: terminated.
02
Drugs
panobinostat
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00848523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848523.